Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics"" wg kryterium: PB


Tytuł:
A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [ C] encorafenib in healthy male subjects.
Autorzy:
Wollenberg L; Pfizer Inc. Worldwide Research, Development and Medical, Boulder, Colorado, USA.
Hahn E; Pfizer Inc. Worldwide Research, Development and Medical, Boulder, Colorado, USA.
Williams J; Pfizer Inc. Worldwide Research, Development and Medical, La Jolla, California, USA.
Litwiler K; Pfizer Inc. Worldwide Research, Development and Medical, Boulder, Colorado, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Oct; Vol. 11 (5), pp. e01140.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*
Melanoma*/drug therapy
Humans ; Male ; Proto-Oncogene Proteins B-raf/therapeutic use ; Sulfonamides
Czasopismo naukowe
Tytuł:
Effects of pharmacological doses of niacin on subacute glucocorticoid-induced testicular damage in rats.
Autorzy:
Azimi Zangabad E; Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Shomali T; Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Roshangar L; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Oct; Vol. 11 (5), pp. e01128.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glucocorticoids*/adverse effects
Niacin*/pharmacology
Testis*/drug effects
Animals ; Male ; Rats ; Dexamethasone ; Electroencephalography ; Evoked Potentials ; Sperm Motility ; Testosterone
Czasopismo naukowe
Tytuł:
Dopaminergic cell protection and alleviation of neuropsychiatric disease symptoms by VMAT2 expression through the class I HDAC inhibitor TC-H 106.
Autorzy:
Lee H; New Drug Development Center, K-Medihub, Daegu, Korea.
Kim HJ; Department of Physiology, School of Medicine, Jeju National University, Jeju, Korea.
Choi DK; New Drug Development Center, K-Medihub, Daegu, Korea.
Ko EN; Department of Physiology, School of Medicine, Jeju National University, Jeju, Korea.
Choi JH; New Drug Development Center, K-Medihub, Daegu, Korea.
Seo Y; New Drug Development Center, K-Medihub, Daegu, Korea.
Lee S; New Drug Development Center, K-Medihub, Daegu, Korea.
Kim SH; New Drug Development Center, K-Medihub, Daegu, Korea.
Jung S; New Drug Development Center, K-Medihub, Daegu, Korea.
Kim M; New Drug Development Center, K-Medihub, Daegu, Korea.
Kang D; New Drug Development Center, K-Medihub, Daegu, Korea.
Im CY; New Drug Development Center, K-Medihub, Daegu, Korea.
Bae GH; New Drug Development Center, K-Medihub, Daegu, Korea.
Jung SC; Department of Physiology, School of Medicine, Jeju National University, Jeju, Korea.
Kwon OB; New Drug Development Center, K-Medihub, Daegu, Korea.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Oct; Vol. 11 (5), pp. e01135.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Histone Deacetylase Inhibitors*/pharmacology
Histone Deacetylase Inhibitors*/therapeutic use
Neuroblastoma*
Humans ; Animals ; Mice ; Vesicular Monoamine Transport Proteins/genetics ; Cytoprotection ; Dopamine ; Oxidopamine
Czasopismo naukowe
Tytuł:
Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain.
Autorzy:
Healy P; Clinical Pharmacology & Therapeutics Group, School of Pharmacy, University College London, London, UK.
Verrest L; Clinical Pharmacology & Therapeutics Group, School of Pharmacy, University College London, London, UK.
Felisi M; CVBF-Consorzio per le Valutazioni Biologiche e Farmacologiche, Pavia, Italy.
Ceci A; Fondazione per la Ricerca Farmacologica Gianni Benzi onlus, Valenzano, Italy.
Della Pasqua O; Clinical Pharmacology & Therapeutics Group, School of Pharmacy, University College London, London, UK.
Pokaż więcej
Corporate Authors:
GAPP Consortium
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Oct; Vol. 11 (5), pp. e01138.
Typ publikacji:
Journal Article
MeSH Terms:
Tramadol*/adverse effects
Chronic Pain*/drug therapy
Analgesia*
Adult ; Humans ; Child ; Infant ; Gabapentin/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł:
Investigation of the GnRH antagonist degarelix isomerization in biological matrices.
Autorzy:
Ferrazzano L; Department of Chemistry 'Giacomo Ciamician', Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Tolomelli A; Department of Chemistry 'Giacomo Ciamician', Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Guryanov I; Fresenius Kabi iPSUM Srl, Villadose (RO), Italy.; Institute of Chemistry, St. Petersburg State University, St. Petersburg, Russia.
Macis M; Fresenius Kabi iPSUM Srl, Villadose (RO), Italy.
Abel U; Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany.
Ricci A; Fresenius Kabi iPSUM Srl, Villadose (RO), Italy.
Cabri W; Department of Chemistry 'Giacomo Ciamician', Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Fresenius Kabi iPSUM Srl, Villadose (RO), Italy.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01117.
Typ publikacji:
Journal Article
MeSH Terms:
Gonadotropin-Releasing Hormone*
Oligopeptides*
Isomerism ; Hormone Antagonists
Czasopismo naukowe
Tytuł:
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a 1 receptor) antagonist.
Autorzy:
Anliker-Ort M; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
Hsin CH; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Krause A; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Pfister M; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
van den Anker J; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
Dingemanse J; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Kaufmann P; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01112.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Factor Va*
Electrocardiography
Czasopismo naukowe
Tytuł:
Could cannabinoids provide a new hope for ovarian cancer patients?
Autorzy:
Kaur R; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Javid FA; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01122.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cannabinoids*/pharmacology
Cannabinoids*/therapeutic use
Cannabis*
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/chemically induced
Female ; Humans ; Vomiting/chemically induced
Czasopismo naukowe
Tytuł:
Analysis of safety specifications in risk management plan at the time of drug approval and addition of clinically significant adverse reactions in the package insert post-approval in Japan.
Autorzy:
Saito R; Division of Social Pharmacy and Regulatory Science, Showa Pharmaceutical University, Machida-shi, Tokyo, Japan.
Miyazaki S; Division of Social Pharmacy and Regulatory Science, Showa Pharmaceutical University, Machida-shi, Tokyo, Japan.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01110.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Approval*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Humans ; Japan ; Product Labeling ; Risk Management
Czasopismo naukowe
Tytuł:
Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis.
Autorzy:
Freeze R; EydisBio, Inc., Durham, North Carolina, USA.
Yang KW; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Haystead T; EydisBio, Inc., Durham, North Carolina, USA.; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Hughes P; EydisBio, Inc., Durham, North Carolina, USA.; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, USA.
Scarneo S; EydisBio, Inc., Durham, North Carolina, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01124.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Arthritis, Rheumatoid*/drug therapy
Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Animals ; Mice ; Etanercept/therapeutic use ; Adalimumab ; Infliximab/therapeutic use ; Cytokines/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł:
How to approach a study in ethnopharmacology? Providing an example of the different research stages for newcomers to the field today.
Autorzy:
Schultz F; Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, UK.; Ethnopharmacology & Zoopharmacognosy Research Group, Department of Agriculture and Food Sciences, Neubrandenburg University of Applied Sciences, Neubrandenburg, Germany.
Garbe LA; Ethnopharmacology & Zoopharmacognosy Research Group, Department of Agriculture and Food Sciences, Neubrandenburg University of Applied Sciences, Neubrandenburg, Germany.; ZELT - Neubrandenburg Center for Nutrition and Food Technology gGmbH, Neubrandenburg, Germany.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01109.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Plants, Medicinal*
Animals ; Ethnopharmacology/methods ; Ethnobotany ; Surveys and Questionnaires ; Research Design
Czasopismo naukowe
Tytuł:
The potencies and neurotoxicity of intrathecal levobupivacaine in a rat spinal model: Effects of concentration.
Autorzy:
Gao L; Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Yang Z; Department of Anesthesiology, North Sichuan Medical College, Nanchong, China.
Zeng S; Department of Anesthesiology, North Sichuan Medical College, Nanchong, China.
Li J; Department of Anesthesiology, North Sichuan Medical College, Nanchong, China.
Wang N; Department of Anesthesiology, North Sichuan Medical College, Nanchong, China.
Wang F; Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01116.
Typ publikacji:
Journal Article; Randomized Controlled Trial, Veterinary; Research Support, Non-U.S. Gov't
MeSH Terms:
Anesthetics, Local*/toxicity
Bupivacaine*/toxicity
Animals ; Rats ; Injections, Spinal ; Levobupivacaine ; Lidocaine/toxicity
Czasopismo naukowe
Tytuł:
Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis.
Autorzy:
Shinogi Y; Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
Hirai T; Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
Ishibashi M; Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
Ino K; Department of Hematology and Oncology, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
Tawara I; Department of Hematology and Oncology, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
Iwamoto T; Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01120.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Antifungal Agents*
Hematopoietic Stem Cell Transplantation*
Adult ; Humans ; Tacrolimus/pharmacokinetics ; Fluconazole/pharmacology ; Fluconazole/therapeutic use ; Retrospective Studies ; Immunosuppressive Agents ; Azoles ; Drug Interactions
Czasopismo naukowe
Tytuł:
Impact of metformin on statin-associated myopathy risks in dyslipidemia patients.
Autorzy:
Bak K; College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Moon S; College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Ko M; College of Pharmacy, Ajou University, Suwon, Republic of Korea.
Choi YJ; Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Shin S; College of Pharmacy, Ajou University, Suwon, Republic of Korea.; Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Republic of Korea.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01114.
Typ publikacji:
Journal Article
MeSH Terms:
Metformin*/adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Muscular Diseases*/chemically induced
Muscular Diseases*/epidemiology
Dyslipidemias*/chemically induced
Dyslipidemias*/drug therapy
Dyslipidemias*/epidemiology
Humans ; Retrospective Studies ; Cohort Studies ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways.
Autorzy:
González A; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.; Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.; High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
García-Gómez-Heras S; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.; High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Franco-Rodríguez R; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
López-Miranda V; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.; Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.; High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Herradón E; Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.; Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.; High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01108.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism
Cardiovascular System*/metabolism
Rats ; Animals ; Male ; Cisplatin ; Signal Transduction ; Toll-Like Receptor 4/metabolism ; Myeloid Differentiation Factor 88/metabolism ; Rats, Wistar ; Kidney/metabolism
Czasopismo naukowe
Tytuł:
An analysis of patterns of distribution of buprenorphine in the United States using ARCOS, Medicaid, and Medicare databases.
Autorzy:
Hsu ZS; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Warnick JA; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Harkins TR; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Sylvester BE; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Bharati NK; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Eley LB; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Nichols SD; Department of Pharmacy Practice, University of New England, Portland, Maine, USA.
McCall K; Department of Pharmacy Practice, Binghamton University, Binghamton, New York, USA.
Piper BJ; Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.; Center for Pharmacy Innovation and Outcomes, Geisinger Precision Heath Center, Pennsylvania, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01115.
Typ publikacji:
Journal Article
MeSH Terms:
Buprenorphine*/therapeutic use
Opioid-Related Disorders*/drug therapy
Opioid-Related Disorders*/epidemiology
Aged ; Humans ; United States ; Medicaid ; Medicare ; Opiate Substitution Treatment
Czasopismo naukowe
Tytuł:
Experimental training in molecular pharmacology education based on drug-target interactions.
Autorzy:
Ge L; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences; NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences); Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.
Cheng K; Department of PET/CT Center, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China.
Zhang Y; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences; NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences); Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.
Li J; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences; NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences); Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.
Chen W; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences; NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences); Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.
Song G; Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, China.
Wang L; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences; NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences); Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01118.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Learning*
Motivation*
Animals ; Mice ; Molecular Docking Simulation
Czasopismo naukowe
Tytuł:
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.
Autorzy:
Santos EJ; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Nassehi N; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Bow EW; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Chambers DR; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Gutman ES; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Jacobson AE; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Lutz JA; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Marsh SA; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA.
Selley DE; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Negus SS; Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, USA.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01111.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
Analgesics, Opioid*/pharmacology
Buprenorphine*/pharmacology
Receptors, Opioid, mu*/agonists
Animals ; Female ; Male ; Mice ; Guanosine 5'-O-(3-Thiotriphosphate) ; Ligands
Czasopismo naukowe
Tytuł:
Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta-analysis of randomized controlled trials.
Autorzy:
Zhou P; Department of Pharmacy, Peking University Third Hospital, Beijing, China.; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
Chen L; Department of Pharmacy, Peking University Third Hospital, Beijing, China.; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.; Department of Pharmacy, Yantai Yuhuangding Hospital, Shandong, China.
Wang E; Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
He L; Department of Pharmacy, Peking University Third Hospital, Beijing, China.; Department of Pharmacy, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Tian S; Department of Pharmacy, Peking University Third Hospital, Beijing, China.; Department of Pharmacy, Tianjin Nankai Hospital, Tianjin, China.
Zhai S; Department of Pharmacy, Peking University Third Hospital, Beijing, China.; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01123.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Ibuprofen*/therapeutic use
Antipyretics*/therapeutic use
Adult ; Humans ; Acetaminophen/therapeutic use ; Randomized Controlled Trials as Topic ; Fever/drug therapy ; Fever/etiology ; Pain, Postoperative/drug therapy
Czasopismo naukowe
Tytuł:
Oral morphine induces spinal 5-hydroxytryptamine (5-HT) release using an opioid receptor-independent mechanism.
Autorzy:
Nakamura S; Department of Anesthesiology, Kumamoto University Hospital, Kumamoto, Japan.
Komatsu S; Department of Anesthesiology, Kumamoto University Hospital, Kumamoto, Japan.
Yamada T; Department of Anesthesiology, Kumamoto University Hospital, Kumamoto, Japan.
Kitahara H; Undergraduate Student, School of Medicine, Kumamoto University, Kumamoto, Japan.
Yamamoto T; Department of Anesthesiology, Kumamoto University Hospital, Kumamoto, Japan.; Department of Anesthesiology, Saitama Medical University Hospital, Saitama, Japan.; Department of Anesthesiology, Funabashi Orthopedic Hospital, Chiba, Japan.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01119.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Opioid*
Serotonin*
Animals ; Rats ; Oxycodone ; Morphine ; Analgesics, Opioid ; Naloxone ; Pain
Czasopismo naukowe
Tytuł:
Application of physiologically based pharmacokinetic modeling to understand real-world outcomes in patients receiving imatinib for chronic myeloid leukemia.
Autorzy:
Adattini JA; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Adiwidjaja J; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Gross AS; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline R&D, Sydney, Australia.
McLachlan AJ; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Aug; Vol. 11 (4), pp. e01082.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Humans ; Imatinib Mesylate/adverse effects ; Imatinib Mesylate/pharmacokinetics ; Cytochrome P-450 CYP2C8 ; Cytochrome P-450 CYP3A
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies